Published by Iain Gilbert on 9th July 2021
(Sharecast News) - Clinical research organisation Open Orphan's hVIVO subsidiary has signed "a significant contract" to test AIM ImmunoTech's antiviral candidate, Ampligen.
URL: http://www.digitallook.com/dl/news/story/31976753/...